Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SerpinPC Open-Label Extension in Hemophilia (PRESent-6)
NCT06568302Phase 3Terminated
- Sponsor
- ApcinteX Ltd.
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of serpinpc in hemophilia A, hemophilia B (HB), sponsored by ApcinteX Ltd.. Started Jul 2024; status: terminated.
02
Drugs
serpinpc
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT06568302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06568302.